Projects funded by the NCN
Insights into biological activity and mechanism of action of novel styrylquinazoline derivatives as tyrosine kinase inhibitors.
2016/23/N/NZ7/00351
Keywords:
styrylquinazolines tyrosine kinase inhibitors multidirectional targeted therapy
Descriptors:
- NZ3_7: Signal transduction
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- ST5_16:
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Śląski w Katowicach, Wydział Matematyki, Fizyki i Chemii
woj. śląskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 3
Call: PRELUDIUM 12 - announced on 2016-09-15
Amount awarded: 99 600 PLN
Project start date (Y-m-d): 2017-09-29
Project end date (Y-m-d): 2019-09-28
Project duration:: 24 months (the same as in the proposal)
Project status: Project settled
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.